# SITELINE 2 Polyurethane

> **NCT00180284** · PHASE3 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 200 (actual)

## Conditions studied

- Bradycardia

## Interventions

- **DEVICE:** SITELINE 2 Polyurethane (pacing lead)

## Key facts

- **NCT ID:** NCT00180284
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2005-05
- **Final completion:** 2008-02
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2011-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00180284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00180284, "SITELINE 2 Polyurethane". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00180284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*